New smart drug targets Hard-to-Treat cancers in early human trial
Disease control
Recruiting now
This study tests a new drug called JK06, which is designed to seek out and attack cancer cells while sparing healthy ones. It is for adults with advanced solid tumors that cannot be removed by surgery or have spread. The main goals are to find the safest dose and see if the drug …
Phase: PHASE1, PHASE2 • Sponsor: Salubris Biotherapeutics Inc • Aim: Disease control
Last updated May 17, 2026 02:07 UTC